Correction to: Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
|---|---|
| Enthalten in: |
European journal of clinical pharmacology - 80(2023), 2 vom: 02. Dez., Seite 301-303 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khiali, Sajad [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© Springer-Verlag GmbH Germany, part of Springer Nature 2023 |
|---|
| doi: |
10.1007/s00228-023-03600-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054661986 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054661986 | ||
| 003 | DE-627 | ||
| 005 | 20240207064616.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240207s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00228-023-03600-6 |2 doi | |
| 035 | |a (DE-627)SPR054661986 | ||
| 035 | |a (SPR)s00228-023-03600-6-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khiali, Sajad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to: Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Springer-Verlag GmbH Germany, part of Springer Nature 2023 | ||
| 700 | 1 | |a Taban-Sadeghi, Mohammadreza |0 (orcid)0000-0001-9577-0099 |4 aut | |
| 700 | 1 | |a Sarbakhsh, Parvin |0 (orcid)0000-0002-4213-5152 |4 aut | |
| 700 | 1 | |a Khezerlouy-Aghdam, Naser |0 (orcid)0000-0001-5446-1492 |4 aut | |
| 700 | 1 | |a Entezari-Maleki, Taher |0 (orcid)0000-0003-3653-3653 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of clinical pharmacology |d Berlin : Springer, 1968 |g 80(2023), 2 vom: 02. Dez., Seite 301-303 |w (DE-627)SPR002560860 |w (DE-600)1459058-X |x 1432-1041 |7 nnns |
| 773 | 1 | 8 | |g volume:80 |g year:2023 |g number:2 |g day:02 |g month:12 |g pages:301-303 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00228-023-03600-6 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 80 |j 2023 |e 2 |b 02 |c 12 |h 301-303 | ||